Australia & New Zealand

The Accord strategy for Australia & New Zealand market is primarily based on establishing collaborating alliances with the world’s major generic partners. Over the last 9 years, we have established more than 15 strategic relationships for 29 products. We continuously seek to expand our existing partnerships to new products and establish new relationships in this region.

Our current portfolio consists of Oncology, Urology, Cardiovascular, Neurology, Diabetology and other therapeutic segments.